NEURAXIS, INC. Increase (Decrease) in Accounts Receivable
NEURAXIS, INC. (NRXS) reported Increase (Decrease) in Accounts Receivable of $250.26 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- NEURAXIS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $61.06K.
- NEURAXIS, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $189.20K.
- NEURAXIS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $87.33K, a 50.46% decline year-over-year.
- NEURAXIS, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$17.81K.
- NEURAXIS, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$46.59K, a 126.05% decline from fiscal 2024.
- NEURAXIS, INC. increase (decrease) in accounts receivable for fiscal 2024 was $178.84K.
- NEURAXIS, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$75.95K, a 196.63% decline from fiscal 2022.
- NEURAXIS, INC. increase (decrease) in accounts receivable for fiscal 2022 was $78.60K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $61.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $250.26K 10-Q · filed 2026-08-11 | $337.58K derived: sum of 3 quarters · filed 2026-08-11 | $319.77K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $189.20K 10-Q · filed 2026-05-12 | $276.52K derived: sum of 2 quarters · filed 2026-05-12 | $258.71K derived: sum of 3 quarters · filed 2026-05-12 | $143.52K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $87.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $69.51K derived: sum of 2 quarters · filed 2026-03-19 | -$45.68K derived: sum of 3 quarters · filed 2026-08-11 | -$46.59K 10-K · filed 2026-03-19 |
| 2025-09-30 | -$17.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$133.00K derived: sum of 2 quarters · filed 2026-08-11 | -$133.91K 10-Q · filed 2025-11-10 | $42.35K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | -$115.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$116.10K 10-Q · filed 2026-08-11 | $60.16K derived: sum of 3 quarters · filed 2026-08-11 | -$31.22K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | -$910.00 10-Q · filed 2026-05-12 | $175.35K derived: sum of 2 quarters · filed 2026-05-12 | $83.97K derived: sum of 3 quarters · filed 2026-05-12 | $146.93K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $176.26K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $84.88K derived: sum of 2 quarters · filed 2026-03-19 | $147.84K derived: sum of 3 quarters · filed 2026-03-19 | $178.84K 10-K · filed 2026-03-19 |
| 2024-09-30 | -$91.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$28.42K derived: sum of 2 quarters · filed 2025-11-10 | $2.58K 10-Q · filed 2025-11-10 | -$37.73K derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $62.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $93.96K 10-Q · filed 2025-08-12 | $53.65K derived: sum of 3 quarters · filed 2025-08-12 | -$48.69K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $31.00K 10-Q · filed 2025-05-12 | -$9.31K derived: sum of 2 quarters · filed 2025-05-12 | -$111.65K derived: sum of 3 quarters · filed 2025-05-12 | -$230.25K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$40.31K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$142.65K derived: sum of 2 quarters · filed 2025-03-20 | -$261.25K derived: sum of 3 quarters · filed 2025-03-20 | -$75.95K 10-K · filed 2025-03-20 |
| 2023-09-30 | -$102.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$220.94K derived: sum of 2 quarters · filed 2024-11-12 | -$35.64K 10-Q · filed 2024-11-12 | -$204.77K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$118.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $66.70K 10-Q · filed 2024-08-09 | -$102.44K derived: sum of 3 quarters · filed 2024-08-09 | $13.54K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $185.30K 10-Q · filed 2024-05-20 | $16.16K derived: sum of 2 quarters · filed 2024-05-20 | $132.14K derived: sum of 3 quarters · filed 2024-05-20 | |
| 2022-12-31 | -$169.13K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$53.16K derived: sum of 2 quarters · filed 2024-04-16 | $78.60K 10-K · filed 2024-04-16 | |
| 2022-09-30 | $115.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $247.74K 10-Q · filed 2023-11-20 | ||
| 2022-06-30 | $131.76K 10-Q · filed 2023-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |